Main page content

Displaying results 1 - 8 of 8
Publication ID: PEP21-02-01-003
Published:

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

Publication ID: PEP21-02-01-002
Published:

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.

Publication ID: PEP21-PL-Guide-5
Published:

This guide examines emerging and best practices for initiating medication-assisted treatment in emergency departments. It also reviews the existing literature and science of the topic, identifies gaps in knowledge, and discusses challenges of implementation.

Publication ID: PEP20-03-03-017
Published:

 Consejos para adolescentes: la realidad sobre el tabaco

This fact sheet for teens provides facts about tobacco. It describes short- and long-term effects, lists signs of use, and helps dispel common myths. It also can be used by prevention professionals, educators, health care providers, and others who come in contact with teens on a regular basis.

Publication ID: PEP20-03-03-006
Published:

Consejos para adolescentes: la realidad sobre los cigarrillos electrónicos

This fact sheet for teens provides facts about vaping. It describes short- and long-term effects and lists signs of vaping. The fact sheet helps to dispel common myths about vaping. Access sources and references cited in this fact sheet.

Publication ID: PEP19-12
Published:

This fact sheet for teens provides facts about vaping. It describes short- and long-term effects and lists signs of vaping. The fact sheet helps to dispel common myths about vaping. Access sources and references cited in this fact sheet.

Publication ID: SMA16-4938
Published:

This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.

Publication ID: SMA15-4442
Published:

This brochure informs patients about buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.